| Identification | Back Directory | [Name]
2-Hydroxy-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]acetamide | [CAS]
914465-63-7 | [Synonyms]
2-Hydroxy-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]acetamide
2-Hydroxy-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]acetamide
N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-hydroxyacetamide
Acetamide, 2-hydroxy-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | [Molecular Formula]
C16H15N5O2 | [MOL File]
914465-63-7.mol | [Molecular Weight]
309.32 |
| Chemical Properties | Back Directory | [density ]
1.340±0.06 g/cm3(Predicted) | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
4.16±0.10(Predicted) | [color ]
White to Off-White |
| Hazard Information | Back Directory | [Uses]
2-Hydroxy-N-[[2''-(2H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl]acetamide is a degradation product of losartan potassium in an extemporaneous suspension formulation. |
|
|